# Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS

> **NCT00761683** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 105 (estimated)

## Conditions studied

- Endometriosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00761683
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 105 (ESTIMATED)
- **Why stopped:** Anticipated number of patients not achieved. All Patients recruited in the study completed all study visits.
- **Last updated:** 2009-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761683, "Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00761683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*